SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007321
Filing Date
2021-05-17
Accepted
2021-05-17 06:58:22
Documents
44
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20210331x10q.htm 10-Q 801685
2 EX-10.1 mist-20210331ex101d45a2f.htm EX-10.1 22952
3 EX-31.1 mist-20210331ex3111c8f27.htm EX-31.1 12315
4 EX-31.2 mist-20210331ex312efa4a8.htm EX-31.2 12466
5 EX-32.1 mist-20210331ex321633f31.htm EX-32.1 9435
  Complete submission text file 0001558370-21-007321.txt   3690537

Data Files

Seq Description Document Type Size
6 EX-101.INS mist-20210331.xml EX-101.INS 874717
7 EX-101.SCH mist-20210331.xsd EX-101.SCH 23416
8 EX-101.CAL mist-20210331_cal.xml EX-101.CAL 26857
9 EX-101.DEF mist-20210331_def.xml EX-101.DEF 86049
10 EX-101.LAB mist-20210331_lab.xml EX-101.LAB 244987
11 EX-101.PRE mist-20210331_pre.xml EX-101.PRE 181447
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 21927445
SIC: 2834 Pharmaceutical Preparations